International Development Committee
3 November 2026
Contents updated on 4 Nov 2026
Legend
Transcript markers
- text Sentence being played
- text Search result
- text Intervention cited by the link you opened
Click a sentence to play the video from that moment. Select text to quote it with the speaker, timestamp and link.
More options
Official source
Offset
Transcript offset
0s
Text size
Export
Replay
Versions of this video
Transcripts may differ slightly from one version to another.
International Development Committee House of Commons
Follow its sittings00:05 - 00:33
Speaker 1
Order. Thank you for joining us at the International Development Select Committee to our witnesses on panel one. We're looking specifically at the humanitarian situation in Ukraine. It's with great sadness that we're having this session and the war is continuing. Thank you for making the time to be with us.
If I could ask the witnesses to introduce themselves. Elena, could you introduce yourself and who you work for?
00:33 - 01:15
Speaker 3
Sure. Thank you very much for invitation, and I'm Elena Moshynets, Dr Elena Moshynets. I'm a Leading Research Fellow at the Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine, where I lead the biofilm study group. I'm microbiologist myself, and I'm specializing in antimicrobial resistance, bacterial biofilms and multidrug-resistant infections. I also coordinate the Horizon Europe SURVIVE project aimed at strengthening Ukraine's AMR research capacities through international cooperation in a One Health approach.
And my current work is particularly focused on the challenges of treating highly resistant bacterial infections in wartime Ukraine, including combat-related infections. Thank you.
01:15 - 01:19
Speaker 1
Thank you very much. And Dr Luke, if you could introduce yourself and your work?
01:19 - 01:43
Speaker 4
Good afternoon, so my name is Luke Moore. I'm a consultant medic here in London at Chelsea and Westminster Hospital, but then in my spare time I'm an academic at Imperial College London, where I focus on antibiotic resistance and how we as a global community can address that. I'm a member of various learned societies, including editor of the Journal of Hospital Infection, where we focus on how, as a globe, we can combat antibiotic resistance.
01:43 - 02:06
Speaker 1
You're both very busy and very valuable people, so thank you for making the time today. Elena, I wonder, could you give us an overview of the current healthcare situation in Ukraine? And then maybe if you could sort of, no, I'll ask Dr Luke to go into the antimicrobial, but just the general health situation, please.
02:06 - 02:38
Speaker 2
Sure, thank you. Let me try to guide you through the problem which we have now with medical system care in Ukraine. And I should start here from Ukraine, the fact that Ukraine healthcare system in a reformation, a stage of reformation. We have this reform launched from 2022, and the aim of this reform is to bring healthcare financing and service delivery closer to Western standards. However, it began in the same year as Russia's full-scale invasion, and continued despite the unprecedented challenges imposed by the war.
02:38 - 03:44
Speaker 3
This is actually without adequate adaptation to the new realities or sufficient consideration of the rapidly deteriorating healthcare infrastructures, financing constraints, and changing needs in medical needs. So, as a result, the healthcare system has been expected to implement extensive structural and regulatory changes under wartime conditions without sufficient financial financing resources, institutional preparation, or workflow development. In particular, Ukraine lacks a comprehensive system of national clinical guidelines as guidelines for antimicrobial treatment, sufficient number of trained specialists in antimicrobial resistance and infection prevention and control, and dedicated hospital fundings to implement the new requirements. So I would say that infection prevention and control is of particular difficult to implement in those circumstances. Low salaries, shot staff shortage, and extensive workloads severely influenced resulted in the problems which we have now with infection prevention and control requirements.
03:44 - 03:53
Speaker 2
In some hospitals, one nurse is responsible for 40-60 beds, making consistent implementation of basic infection prevention measures extremely difficult.